National Medical Care Co., providing medical services and operation and management of hospitals, reported SAR 92.5m net profit at the end of 2013, a 12% decrease compared to last year, as shown in the following table:
Item | 2012 | 2013 | Change |
---|---|---|---|
Revenues | 524.75 | 586.28 | 11.7 % |
Gross Income | 135.13 | 130.06 | (3.8 %) |
Operating Income | 104.01 | 91.55 | (12.0 %) |
Net Income | 104.96 | 92.50 | (11.9 %) |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 2.34 | 2.06 | (11.9 %) |
Item | Q4 2012 | Q4 2013 | Change |
---|---|---|---|
Revenues | 137.61 | 164.16 | 19.3 % |
Gross Income | 31.93 | 33.54 | 5.0 % |
Operating Income | 23.24 | 21.42 | (7.8 %) |
Net Income | 25.03 | 20.39 | (18.6 %) |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 0.56 | 0.45 | (18.6 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2013 | 145.36 | 12.8 % | 38.75 | 9.0 % | 31.05 | 8.0 % |
Q2 2013 | 142.20 | 3.6 % | 31.78 | (15.5 %) | 21.64 | (28.8 %) |
Q3 2013 | 134.56 | 11.2 % | 24.08 | (19.9 %) | 17.45 | (19.3 %) |
Q4 2013 | 164.16 | 19.3 % | 33.54 | 5.0 % | 21.42 | (7.8 %) |
2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 91.55 | (12.0 %) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2013 | 31.12 | 7.8 % | 0.69 | - | 31.12 | 0.69 |
Q2 2013 | 22.19 | (25.0 %) | 0.49 | - | 22.19 | 0.49 |
Q3 2013 | 18.80 | (12.4 %) | 0.42 | - | 18.80 | 0.42 |
Q4 2013 | 20.39 | (18.6 %) | 0.45 | - | 20.39 | 0.45 |
2013 | 92.50 | (11.9 %) | 2.06 | - | 92.50 | 2.06 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2013 | 25.56 % | 24.89 % | 19.81 % |
Q2 2013 | 24.27 % | 23.17 % | 18.27 % |
Q3 2013 | 22.61 % | 21.99 % | 17.36 % |
Q4 2013 | 21.86 % | 20.98 % | 15.78 % |
2013 | 22.18 % | 20.98 % | 15.78 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2013 | 44.85 | 2.39 | 2.39 | 18.19 |
Q2 2013 | 44.85 | 2.23 | 2.23 | 17.24 |
Q3 2013 | 44.85 | 2.17 | 2.17 | 17.65 |
Q4 2013 | 44.85 | 2.06 | 2.06 | 18.11 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2013 | 30.02 | 30.02 | 3.94 |
Q2 2013 | 26.07 | 26.07 | 3.37 |
Q3 2013 | 25.16 | 25.16 | 3.09 |
Q4 2013 | 26.43 | 26.43 | 3.01 |
Q4 2013
Period | Medical Services | Pharmacies |
---|---|---|
Q1 2013 | 117.72 | 27.65 |
Q2 2013 | 115.21 | 26.98 |
Q3 2013 | 109.28 | 25.28 |
Q4 2013 | 134.04 | 30.12 |
Current | |
Market Cap (M Riyal) | 7,516.86 |
Enterprise Value (EV) (M) | 7,501.35 |
Shares Outstanding ((M)) | 44.85 |
EPS ( Riyal) (TTM) | 6.12 |
Book Value (BV) ( Riyal) | 34.35 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 30.63 |
P/E (TTM) | 27.39 |
Price/book | 4.88 |
Return on Average Assets (%) (TTM) | 13.3 |
Return on Average Equity (%) (TTM) | 18.7 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}